7 assets in Mediastinal Gray Zone Lymphoma

Therapeutic assets addressing Mediastinal Gray Zone Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Adriamycin Mediastinal Gray Zone Lymphoma	David Bond, MD	P2	CCC (53)
Cyclophosphamide Mediastinal Gray Zone Lymphoma	David Bond, MD	P2	CCC (53)
Etoposide Mediastinal Gray Zone Lymphoma	David Bond, MD	P2	CCC (53)
Nivolumab Mediastinal Gray Zone Lymphoma	David Bond, MD	P2	CCC (53)
Prednisone Mediastinal Gray Zone Lymphoma	David Bond, MD	P2	CCC (53)
Rituximab Mediastinal Gray Zone Lymphoma	David Bond, MD	P2	CCC (53)
Vincristine Sulfate Mediastinal Gray Zone Lymphoma	David Bond, MD	P2	CCC (53)